ReviewMultiple sclerosis (Houndmills, Basingstoke, England)2014

Risk evaluation and monitoring in multiple sclerosis therapeutics.

Michel C Clanet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.